Suppliers / Italfarmaco

Italfarmaco

Italy 627 employees Updated 9 July 2026

Italfarmaco is a finished-dose manufacturer based in Italy. It appears in 744 regulatory filings across 24 regulators, without an active US DMF or CEP on file. Its filings concentrate with AIFA (IT), AEMPS (ES) and EMA. Its GMP standing is certified by EMA, ANVISA (Brazil) and AEMPS (ES). Its most recent recorded inspection, by US FDA, closed on 15 July 2021 as VAI.

0
active US DMFs
0
valid CEPs
11
registered plants 2 with an FDA FEI number
744
filings across 24 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 15 July 2021 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Milan, United Arab Emirates Not on file
Madrid, United Arab Emirates Not on file
Madrid, Spain Not on file
Spain, Spain 3007048260
Alcobendas, Spain Not on file
MILANO, Italy Not on file

5 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
AIFA (IT) 350 None
AEMPS (ES) 174 1
EMA 87 2
INFARMED (PT) 46 None
US FDA 14 None
MPA (SE) 13 None
ANVISA (Brazil) None 1

Comparing suppliers?

Choose your molecules and target markets. Italfarmaco comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 15 July 2021.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates